Can Denmark’s world-beating drugs maker stay ahead?
Thanks to its weight loss drug, Novo Nordisk briefly became Europe’s most valuable firm in 2023.
Similar Posts
What are nitazenes? What to know about the drug that can be 10 times as potent as fentanyl
Colorado law enforcement warning about opioid recently showing up in overdose toxicology reports Colorado law enforcement warning about opioid recently showing up in overdose toxicology reports 01:13 An overdose death in Colorado has been linked to a new formulation of nitazenes, a class of powerful opioid analgesics being increasingly seen in the illicit drug market….
We Asked Experts What You Should Do If You Overdose On Weed
Most cannabis products that you can buy legally list the amount of THC they contain. However, if you’re consuming an edible that isn’t packaged, it’s almost impossible to tell how much THC, the psychoactive ingredient, is in food, drink, or smoking products. Generally, the likelihood of experiencing uncomfortable effects is higher if you’re a first-time…
Covid inquiry: UK’s public services were ‘depleted’ when Covid hit
The nation’s health was declining and the NHS was struggling by 2020, the Covid inquiry hears.
Why Covid is still flooring some people
A lot of us know someone who has felt pretty rough with the most recent form of the virus.
Biden administration’s Medicare drug price negotiations will face major tests in 2024
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images U.S. patients and drugmakers will get a first glimpse of how much Medicare can negotiate down drug prices in 2024, setting the…
Edwards Lifesciences cooperating with EU antitrust regulators | Reuters News Agency
Health 27 September 2023, 2:03 pm 1 minute Reuters exclusively reported that US medical device maker Edwards Lifesciences, a global leader in its field, was the target of an EU antitrust raid a week ago on concerns that it may have abuse its market power. Shares in Edwards Lifesciences shed 2.5% in pre-market trade on…
